ASK REDCHAT ANYTHING ABOUT ROCKWELL MEDICAL INC.
Rockwell Medical Inc. (NASDAQ: RMTI)
Listen to this Section
$0.69
+0.0103
(
+1.52% )
261.2K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Triferic® AVNU (ferric pyrophosphate citrate)DetailsChronic kidney disease, Psoriasis, Kidney disease |
Approved |
| Triferic (ferric pyrophosphate citrate)DetailsAnemia (hemodialysis dependent chronic kidney disease) |
Approved |
Market Data
|
| Open |
$0.69 |
| Previous Close |
$0.68 |
| Volume |
261.2K |
| Market Cap |
$26.67M |
| Day Range |
$0.67 - $0.72 |
| 52 Week Range |
$0.66 - $2.10 |
| Shares Outstanding |
39.47M |
| Change % |
+1.52% |
| Net Change |
▲ 0.0103 |
| Insider Ownership |
0.00% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 1998 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-505,234.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-03-15 |
Sale |
-100000.00 |
Strobeck Mark |
| 2024-03-15 |
Sale |
-50000.00 |
TIMMINS MEGAN C. |
| 2023-10-18 |
Sale |
-75000.00 |
Neri Jesse |
| 2023-10-18 |
Sale |
-25000.00 |
Lau Joan |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| schedule |
Other |
1 |
Nov 14, 2025 |
| 8-k |
8K-related |
14 |
Nov 12, 2025 |
| 10-q |
Quarterly Reports |
89 |
Nov 12, 2025 |
| 8-k |
8K-related |
30 |
Nov 12, 2025 |
| 3 |
Insider transactions |
2 |
Oct 08, 2025 |
| 4 |
Insider transactions |
1 |
Oct 08, 2025 |
| 4 |
Insider transactions |
1 |
Oct 01, 2025 |
| 4 |
Insider transactions |
1 |
Oct 01, 2025 |
| 4 |
Insider transactions |
1 |
Oct 01, 2025 |
| 8-k |
8K-related |
13 |
Sep 29, 2025 |